{"id":85,"date":"2019-02-18T16:16:52","date_gmt":"2019-02-18T15:16:52","guid":{"rendered":"http:\/\/radiotransnet.fr\/?page_id=85"},"modified":"2025-08-22T11:39:39","modified_gmt":"2025-08-22T09:39:39","slug":"publications","status":"publish","type":"page","link":"https:\/\/radiotransnet.fr\/index.php\/accueil\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"\n<p>Vous trouverez ici les donn\u00e9es de l&rsquo;observatoire de la recherche pr\u00e9clinique 2022<\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\"  class=\"wp-block-file__embed\" data=\"https:\/\/radiotransnet.fr\/wp-content\/uploads\/2025\/08\/ObservatoireRecherchePreclinique_2022.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Contenu embarqu\u00e9 ObservatoireRecherchePreclinique_2022.\"><\/object><a id=\"wp-block-file--media-e115b5be-faa8-4a13-b540-bdff2f1bab02\" href=\"https:\/\/radiotransnet.fr\/wp-content\/uploads\/2025\/08\/ObservatoireRecherchePreclinique_2022.pdf\">ObservatoireRecherchePreclinique_2022<\/a><a href=\"https:\/\/radiotransnet.fr\/wp-content\/uploads\/2025\/08\/ObservatoireRecherchePreclinique_2022.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-e115b5be-faa8-4a13-b540-bdff2f1bab02\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"768\" src=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/CanRad.jpg\" alt=\"\" class=\"wp-image-2006\" style=\"width:363px;height:491px\" srcset=\"https:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/CanRad.jpg 568w, https:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/CanRad-222x300.jpg 222w\" sizes=\"(max-width: 568px) 100vw, 568px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"has-small-font-size\"><em>Brief communication<\/em><\/p>\n\n\n\n<p class=\"has-medium-font-size\">RadioTransNet, Radiotherapy Translational and Preclinical Research Network: Results from the dedicated French cancer institute (INCa) call for projects<\/p>\n\n\n\n<p class=\"has-medium-font-size\">RadioTransNet, r\u00e9seau national de recherche pr\u00e9clinique en radioth\u00e9rapie : r\u00e9sultats de l\u2019appel \u00e0 projets de l\u2019Institut National du Cancer<\/p>\n\n\n\n<p class=\"has-small-font-size\">\u00c9 Bayart, R De Crevoisier, A Laprie, F Milliat, Y Prezado, V Marchesi , P Maingon<\/p>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"https:\/\/doi.org\/10.1016\/j.canrad.2023.06.019\">https:\/\/doi.org\/10.1016\/j.canrad.2023.06.019<\/a><br><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>Ne manquez pas les volumes <a href=\"https:\/\/www.sciencedirect.com\/bookseries\/international-review-of-cell-and-molecular-biology\/vol\/376\/suppl\/C\">376<\/a> et <a href=\"https:\/\/www.sciencedirect.com\/bookseries\/international-review-of-cell-and-molecular-biology\/vol\/378\/suppl\/C\">378<\/a> de l&rsquo;<a href=\"https:\/\/www.sciencedirect.com\/bookseries\/international-review-of-cell-and-molecular-biology\"><em>International Review of Cell and Molecular Biology<\/em><\/a> \u00e9dit\u00e9s par C\u00e9line Mirjolet (Centre Georges Fran\u00e7ois Leclerc, Dijon, France) et Lorenzo Galluzzi (Weill Cornell Medical College, New York, NY, United States) enti\u00e8rement d\u00e9di\u00e9s \u00e0 la th\u00e9matique \u00ab\u00a0<strong><em>Ionizing Radiation and the Immune Response<\/em><\/strong>\u00ab\u00a0<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-2 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large is-resized\"><a href=\"https:\/\/www.sciencedirect.com\/bookseries\/international-review-of-cell-and-molecular-biology\/vol\/376\/suppl\/C\"><img loading=\"lazy\" decoding=\"async\" width=\"682\" height=\"1024\" src=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/Ionizing-Radiation-and-the-Immune-Response-A-1-682x1024.jpg\" alt=\"\" class=\"wp-image-2002\" style=\"width:351px;height:526px\" srcset=\"https:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/Ionizing-Radiation-and-the-Immune-Response-A-1-682x1024.jpg 682w, https:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/Ionizing-Radiation-and-the-Immune-Response-A-1-200x300.jpg 200w, https:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/Ionizing-Radiation-and-the-Immune-Response-A-1.jpg 719w\" sizes=\"(max-width: 682px) 100vw, 682px\" \/><\/a><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full is-resized\"><a href=\"https:\/\/www.sciencedirect.com\/bookseries\/international-review-of-cell-and-molecular-biology\/vol\/378\/suppl\/C\"><img loading=\"lazy\" decoding=\"async\" width=\"400\" height=\"600\" src=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/Ionizing-Radiation-and-the-Immune-Response-B.jpg\" alt=\"\" class=\"wp-image-2003\" style=\"width:351px;height:526px\" srcset=\"https:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/Ionizing-Radiation-and-the-Immune-Response-B.jpg 400w, https:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/08\/Ionizing-Radiation-and-the-Immune-Response-B-200x300.jpg 200w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>Le 25 Novembre dernier s&rsquo;est tenu le WS RadiotransNet \u00ab\u00a0Recherche Pr\u00e9clinique en Protonth\u00e9rapie et Hadronth\u00e9rapie. Vous trouverez ici les comptes-rendu des ateliers de cette journ\u00e9e d&rsquo;\u00e9changes.<\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-60b5a830-ef8b-4632-9de3-5b2aee43482f\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/02\/CR-Ateliers-WS-Hadrontherapie.pdf\">CR-Ateliers-WS-Hadrontherapie<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2023\/02\/CR-Ateliers-WS-Hadrontherapie.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-60b5a830-ef8b-4632-9de3-5b2aee43482f\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>MEDIRAD Project launches Recommendations to enhance medical radiation protection :<\/p>\n\n\n\n<p><a href=\"http:\/\/medirad-project.eu\/recommendations\/\" target=\"_blank\" rel=\"noreferrer noopener\">http:\/\/medirad-project.eu\/recommendations\/<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Proposition de feuille de route (r\u00e9dig\u00e9e \u00e0 partir des synth\u00e8ses des workshops) :<\/strong><\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-06e6ee8e-762f-4ff7-bdf1-994677329db9\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2022\/02\/Feuille-de-route-RTN.pdf\">Feuille-de-route-RTN<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2022\/02\/Feuille-de-route-RTN.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-06e6ee8e-762f-4ff7-bdf1-994677329db9\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading has-medium-font-size\">RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM<\/h1>\n\n\n\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Maingon+P&amp;cauthor_id=34862132\">P Maingon<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34862132\/#affiliation-1\"> 1 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Marchesi+V&amp;cauthor_id=34862132\">V Marchesi<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34862132\/#affiliation-2\"> 2 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Azria+D&amp;cauthor_id=34862132\">D Azria<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34862132\/#affiliation-3\"> 3 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Balosso+J&amp;cauthor_id=34862132\">J Balosso<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34862132\/#affiliation-4\"> 4 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Deutsch+%C3%89&amp;cauthor_id=34862132\">\u00c9 Deutsch<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34862132\/#affiliation-5\"> 5 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Cohen+Jonathan-Moyal+%C3%89&amp;cauthor_id=34862132\">\u00c9 Cohen Jonathan-Moyal<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34862132\/#affiliation-6\"> 6 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Giraud+P&amp;cauthor_id=34862132\">P Giraud<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34862132\/#affiliation-7\"> 7 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Bayart+%C3%89&amp;cauthor_id=34862132\">\u00c9 Bayart<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34862132\/#affiliation-8\"> 8<\/a><\/sup> Affiliations<\/p>\n\n\n\n<ul>\n<li>PMID: <strong>34862132<\/strong><\/li>\n\n\n\n<li>DOI: <a rel=\"noreferrer noopener\" href=\"https:\/\/doi.org\/10.1016\/j.canrad.2021.08.003\" target=\"_blank\">10.1016\/j.canrad.2021.08.003<\/a><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"has-black-color has-text-color\"><strong>Dossier de Renouvellement de la labellisation de RadioTransNet :<\/strong><\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-94f868ae-fc6a-4156-8b32-abf6a260d8ff\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2022\/02\/AAC_labellisation-reseau-Radiotherapie-_RTH-2022_Candidature-RadioTransNet-_final-1.pdf\">AAC_labellisation-reseau-Radiotherapie-_RTH-2022_Candidature-RadioTransNet-_final-1<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2022\/02\/AAC_labellisation-reseau-Radiotherapie-_RTH-2022_Candidature-RadioTransNet-_final-1.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-94f868ae-fc6a-4156-8b32-abf6a260d8ff\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-22751424-87cf-4439-85b1-3de1a057a5d6\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2021\/10\/20201211_CR_TablesRondes_WS_CombinedTreatments-1.pdf\">20201211_CR_TablesRondes_WS_\u00a0\u00bbCombined Treatments\u00a0\u00bb<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2021\/10\/20201211_CR_TablesRondes_WS_CombinedTreatments-1.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-22751424-87cf-4439-85b1-3de1a057a5d6\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-49fea23b-4af8-490f-b2a3-ffb49cf0b711\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/11\/2020_RTN_LaLettreInfo_Octobre.pdf\">2020_RTN_LaLettreInfo_Octobre<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/11\/2020_RTN_LaLettreInfo_Octobre.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-49fea23b-4af8-490f-b2a3-ffb49cf0b711\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<p>Rap<strong>port d&rsquo;activit\u00e9 2020 :<\/strong><\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-5ae5bfca-ee24-43f4-af2d-9cf47e35a011\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2022\/02\/RADIOTRANSNET_RapportActivite_022021.pdf\">RADIOTRANSNET_RapportActivite_022021<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2022\/02\/RADIOTRANSNET_RapportActivite_022021.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-5ae5bfca-ee24-43f4-af2d-9cf47e35a011\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-02f07d87-93bb-4116-9093-4d88b8bc1d3e\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/11\/20191213_CR_TableRonde_-WS_NormalTissue.pdf\">20191213_CR_TableRonde_-WS_NormalTissue<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/11\/20191213_CR_TableRonde_-WS_NormalTissue.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-02f07d87-93bb-4116-9093-4d88b8bc1d3e\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<p>Le 12 d\u00e9cembre 2019 s\u2019est tenu \u00e0 l\u2019IRSN  (<a rel=\"noreferrer noopener\" href=\"https:\/\/www.irsn.fr\" target=\"_blank\">https:\/\/www.irsn.fr<\/a>) le workshop Radiotransnet sur l\u2019interaction des radiations ionisantes sur les tissus sains. A cette occasion, Philippe Maingon, un des deux coordinateurs scientifiques du r\u00e9seau, ainsi que Fabien Milliat, responsable du Laboratoire de Radiobiologie des expositions m\u00e9dicales \u00e0 l&rsquo;IRSN, ont \u00e9t\u00e9 interview\u00e9s.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/01\/Radiotransnet3-1-1024x576.png\" alt=\"\" class=\"wp-image-1784\" srcset=\"https:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/01\/Radiotransnet3-1-1024x576.png 1024w, https:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/01\/Radiotransnet3-1-300x169.png 300w, https:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/01\/Radiotransnet3-1-768x432.png 768w, https:\/\/radiotransnet.fr\/wp-content\/uploads\/2020\/01\/Radiotransnet3-1.png 1280w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Le projet RADIOTRANSNET est un\nprojet de structuration de la recherche pr\u00e9clinique pour la radioth\u00e9rapie en\nFrance, d\u00e9pos\u00e9 par la Soci\u00e9t\u00e9 Fran\u00e7aise de Radioth\u00e9rapie Oncologique et la\nSoci\u00e9t\u00e9 Fran\u00e7aise de Physique M\u00e9dicale. Il est financ\u00e9 par l\u2019Institut National\ndu Cancer (INCa).<\/p>\n\n\n\n<p>L\u2019IRSN est partenaire de ce\nprojet, d\u00e9pos\u00e9 par la SFRO et la SFPM, et si\u00e8ge \u00e0 son conseil scientifique.<\/p>\n\n\n\n<p><strong>Philippe Maingon, vous \u00eates directeur m\u00e9dical du d\u00e9partement\nm\u00e9dico-universitaire \u00e0 la Piti\u00e9-Salp\u00eatri\u00e8re, comprenant les services\nd\u2019oncologie radioth\u00e9rapie, et un des deux coordinateurs scientifiques de ce\nr\u00e9seau, pouvez-vous nous en dire plus sur la gen\u00e8se du projet, ses ambitions et\nles acteurs qu&rsquo;il f\u00e9d\u00e8re ?<\/strong><\/p>\n\n\n\n<p>Philippe Maingon&nbsp;: le projet\nest n\u00e9 de la constatation que la recherche clinique et pr\u00e9clinique en France\navait besoin d\u2019\u00eatre structur\u00e9e. Etant donn\u00e9 qu\u2019un certain nombre de\nlaboratoires dispers\u00e9s sur le territoire national avaient des activit\u00e9s qui\nn\u2019\u00e9taient pas forc\u00e9ment coordonn\u00e9es ensemble et que les grands projets qui\nm\u00e8nent au d\u00e9veloppement de la radioth\u00e9rapie, surtout pour ses nouvelles\nindications, devait faire l\u2019objet d\u2019une structuration en amont, celle-ci a donc\n\u00e9t\u00e9 organis\u00e9e avec l\u2019aide de l\u2019INCa. <\/p>\n\n\n\n<p>Apr\u00e8s un appel d\u2019offres d\u00e9pos\u00e9\npar l\u2019INCa, auquel la SFRO et la SFPM ont r\u00e9pondu conjointement. L\u2019INCa a\nanalys\u00e9 l\u2019ensemble du dossier soumis par les deux soci\u00e9t\u00e9s, l\u2019a valid\u00e9 via un\ncomit\u00e9 international ind\u00e9pendant et a retenu le projet comme \u00e9tant celui \u00e0\npartir duquel la structuration de cette recherche pr\u00e9clinique pouvait \u00eatre\norganis\u00e9e.<\/p>\n\n\n\n<p><strong>Un des ateliers du projet se tient donc \u00e0 l&rsquo;IRSN, sur le th\u00e8me des\neffets de la radioth\u00e9rapie sur tissus sains. Fabien Millat, vous y \u00eates\nresponsable du Laboratoire de Radiobiologie des expositions m\u00e9dicales (LRMED) \u00e0\nl\u2019Institut de radioprotection et de s\u00fbret\u00e9 nucl\u00e9aire (IRSN). Votre \u00e9quipe et\nd\u2019autres \u00e9quipes du p\u00f4le Sant\u00e9 de l\u2019IRSN travaillent sur les effets secondaires\ndes radioth\u00e9rapies. Quelles sont les contributions de l&rsquo;IRSN \u00e0 ce r\u00e9seau et\nquels sont les enrichissements mutuels qui naissent lors de ces ateliers ?<\/strong><\/p>\n\n\n\n<p>Fabien Milliat&nbsp;: l\u2019IRSN\nparticipe \u00e0 ce r\u00e9seau Radiotransnet \u00e0 deux niveaux. <\/p>\n\n\n\n<p>Premi\u00e8rement, l\u2019IRSN est\nrepr\u00e9sent\u00e9 au niveau du comit\u00e9 scientifique de Radiotransnet. Un repr\u00e9sentant\nde l\u2019IRSN y si\u00e8ge donc et participe au comit\u00e9 de pilotage et \u00e0 l\u2019organisation\ndes quatre workshops qui sont et seront organis\u00e9s dans le cadre de ce r\u00e9seau. <\/p>\n\n\n\n<p>Deuxi\u00e8mement, l\u2019IRSN participe\n\u00e9galement en tant qu\u2019acteur, \u00e0 travers ses chercheurs, ses chefs de\nlaboratoires, ses directeurs, en prenant part aux diff\u00e9rents workshops, en\npr\u00e9sentant des travaux si besoin et surtout en participant aux tables-rondes,\nafin de porter la vision qu\u2019ont les personnes de l\u2019IRSN qui travaillent sur ces\nth\u00e9matiques des effets des rayonnements sur les tissus sains : physiciens,\nradiobiologistes, etc\u2026<\/p>\n\n\n\n<p><strong>L&rsquo;IRSN est partenaire du projet Radiotransnet et si\u00e8ge \u00e0 son conseil\nscientifique, aux c\u00f4t\u00e9s notamment d&rsquo;autres acteurs comme l&rsquo;INSERM, le CNRS, le\nCEA, UNICANCER, la SFPM, l&rsquo;APHP et la SFRO. Philippe Maingon, comment sont\nd\u00e9finies finalement les priorit\u00e9s de recherche au sein de celui-ci ?<\/strong><\/p>\n\n\n\n<p>Philippe Maingon&nbsp;: elles ont\n\u00e9t\u00e9 d\u00e9finies \u00e0 deux niveaux particuliers. <\/p>\n\n\n\n<p>Le premier, par l\u2019interm\u00e9diaire\nd\u2019un comit\u00e9 de pilotage, qui a permis de s\u00e9lectionner les questions\nfondamentales que se posaient les cliniciens, eu \u00e9gard au traitement des\npatients. Et \u00e0 partir de ces questions fondamentales, et des incertitudes qui\ntournaient autour de celles-ci, quatre grands axes ont \u00e9t\u00e9 d\u00e9finis. Ils ont \u00e9t\u00e9\n\u00e0 l\u2019origine des quatre workshops, dont trois se sont d\u00e9j\u00e0 tenus, le troisi\u00e8me\n\u00e9tant accueilli par l\u2019IRSN :<\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; le premier sur la d\u00e9finition d\u2019une\ncible, <\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; le deuxi\u00e8me sur la probl\u00e9matique des\ncalculs modernes de doses,<\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; le troisi\u00e8me sur l\u2019interaction entre\nirradiation et tissus sains <\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; et le quatri\u00e8me, qui est programm\u00e9 au\nmois de mars, sera consacr\u00e9 \u00e0 l\u2019\u00e9tude des traitements combin\u00e9s, entre des\nmodulateurs de la radioth\u00e9rapie et la radioth\u00e9rapie.<\/p>\n\n\n\n<p>Le deuxi\u00e8me niveau, qui va\npermettre au r\u00e9seau de donner toute sa dimension et son ampleur, porte sur la\ns\u00e9lection, \u00e0 l\u2019issue des quatre r\u00e9unions que je viens de vous mentionner, de la\nd\u00e9finition des axes de recherche prioritaires. Ces axes vont \u00eatre soumis aux\ndiff\u00e9rentes autorit\u00e9s et aux diff\u00e9rentes capacit\u00e9s de financement des\nrecherches qu\u2019il est possible de mobiliser, ces axes \u00e9tant s\u00e9lectionn\u00e9s par le\ncomit\u00e9 de pilotage.<\/p>\n\n\n\n<p><strong>La radioth\u00e9rapie et ses cons\u00e9quences sur tissus sains font notamment\npartie du projet de recherche ROSIRIS \u00e0 l\u2019IRSN. Fabien Milliat, pouvez-vous\nnous en dire plus sur celui-ci ?<\/strong><\/p>\n\n\n\n<p>Fabien Milliat&nbsp;: le\nprogramme ROSIRIS est un projet engag\u00e9 depuis une dizaine d\u2019ann\u00e9es \u00e0 l(IRSN. Il\ns\u2019agit d\u2019un projet multidisciplinaire, qui fait intervenir plusieurs\nlaboratoires du p\u00f4le PSE Sant\u00e9, de plusieurs services et notamment ceux de\ndosim\u00e9trie et de radiobiologie. L\u2019id\u00e9e globale du programme est de coordonner \u00e0\nl\u2019IRSN un objectif commun afin :<\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d\u2019am\u00e9liorer les connaissances des\neffets biologiques sur les tissus sains,<\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d\u2019am\u00e9liorer les mod\u00e8les pr\u00e9dictifs de\nrisque,<\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d\u2019essayer de combler le d\u00e9ficit de\nconnaissances qu\u2019il y a entre la mani\u00e8re dont l\u2019\u00e9nergie se d\u00e9pose au moment de\nl\u2019irradiation et la survenue des effets les plus tardifs.<\/p>\n\n\n\n<p>Et donc ce programme est organis\u00e9\nen 3 axes :<\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; un axe qui relie la mani\u00e8re dont la\ndose se d\u00e9pose et les \u00e9v\u00e8nements biologiques initiaux qui sont d\u00e9tect\u00e9s par des\ncellules des tissus,<\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; un axe de mod\u00e9lisation de la r\u00e9ponse\ndes cellules \u00e0 l\u2019irradiation,<\/p>\n\n\n\n<p>&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; un axe qui est plut\u00f4t pr\u00e9clinique,\ndonc tr\u00e8s en phase avec le workshop du jour, qui vise \u00e0 confirmer des\nhypoth\u00e8ses m\u00e9canistiques sur des mod\u00e8les exp\u00e9rimentaux afin de mieux comprendre\nles effets sur les tissus sains.<\/p>\n\n\n\n<p><strong>Philippe Maingon, pour terminer, vous nous disiez que le prochain\natelier a lieu en mars 2020 sur le sujet des traitements combin\u00e9s. Vous nous\navez \u00e9galement parl\u00e9 des prochaines \u00e9tapes. Comment cela s\u2019inscrit-il dans le\nfutur plan cancer de l\u2019INCa ?<\/strong><\/p>\n\n\n\n<p>Philippe Maingon&nbsp;: le\nd\u00e9veloppement du r\u00e9seau Radiotransnet s\u2019inscrit compl\u00e8tement dans les priorit\u00e9s\ndu futur d\u00e9veloppement de l\u2019INCa. L\u2019INCa souhaite axer son d\u00e9veloppement vers\nles pathologies les plus difficiles \u00e0 traiter \u00e0 l\u2019heure actuelle, comme le\ncancer du pancr\u00e9as, les tumeurs c\u00e9r\u00e9brales, les cancers p\u00e9diatriques ou des\ntumeurs qui sont consid\u00e9r\u00e9es comme aujourd\u2019hui incurables. <\/p>\n\n\n\n<p>Donc toute cette recherche,\ncoordonn\u00e9e en amont pour comprendre les interactions entre radiations et tissus\nsains, radiation et tumeurs et comment optimiser les index th\u00e9rapeutiques\npropos\u00e9s au cours des traitements des patients, s\u2019inscrit pleinement en amont\nde la volont\u00e9 de l\u2019INCa de d\u00e9velopper ces axes de recherche. C\u2019est donc\nv\u00e9ritablement une strat\u00e9gie dans laquelle s\u2019inscrivent la radioth\u00e9rapie moderne\net le r\u00e9seau Radiotransnet, vis-\u00e0-vis des objectifs nationaux de politique de\nsant\u00e9.<\/p>\n\n\n\n<p><strong>Rapport d&rsquo;activit\u00e9 2019 :<\/strong><\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-7aad1d0f-910b-4ce3-9f5a-d5cef9aa89b4\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2022\/02\/202002_RADIOTRANSNET_RapportActivite_final.pdf\">202002_RADIOTRANSNET_RapportActivite_final<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2022\/02\/202002_RADIOTRANSNET_RapportActivite_final.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-7aad1d0f-910b-4ce3-9f5a-d5cef9aa89b4\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<h1 class=\"wp-block-heading has-medium-font-size\">[RadioTransNet, the French network for preclinical research in oncological radiotherapy]<\/h1>\n\n\n\n<p>[Article in French] <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Bayart+E&amp;cauthor_id=31455590\">E Bayart<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-1\"> 1 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Azria+D&amp;cauthor_id=31455590\">D Azria<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-2\"> 2 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Balosso+J&amp;cauthor_id=31455590\">J Balosso<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-3\"> 3 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Benderitter+M&amp;cauthor_id=31455590\">M Benderitter<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-4\"> 4 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Cohen-Jonathan+Moyal+E&amp;cauthor_id=31455590\">E Cohen-Jonathan Moyal<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-5\"> 5 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Delpon+G&amp;cauthor_id=31455590\">G Delpon<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-6\"> 6 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Deutsch+E&amp;cauthor_id=31455590\">E Deutsch<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-7\"> 7 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Dutreix+M&amp;cauthor_id=31455590\">M Dutreix<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-8\"> 8 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Lacornerie+T&amp;cauthor_id=31455590\">T Lacornerie<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-9\"> 9 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Romeo+PH&amp;cauthor_id=31455590\">P H Romeo<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-10\"> 10 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Marchesi+V&amp;cauthor_id=31455590\">V Marchesi<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-11\"> 11 <\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Maingon+P&amp;cauthor_id=31455590\">P Maingon<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31455590\/#affiliation-12\"> 12<\/a><\/sup> Affiliations<\/p>\n\n\n\n<ul>\n<li>PMID: <strong>31455590<\/strong><\/li>\n\n\n\n<li>DOI: <a target=\"_blank\" rel=\"noreferrer noopener\" href=\"https:\/\/doi.org\/10.1016\/j.canrad.2019.07.155\">10.1016\/j.canrad.2019.07.155<\/a><\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-a010c0db-02ef-43d8-891f-7c7363e9dc93\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/10\/2019_RTN_CompteRendu_WS_DM.docx\">2019_RTN_CompteRendu_WS_\u00a0\u00bbDose Modelling\u00a0\u00bb<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/10\/2019_RTN_CompteRendu_WS_DM.docx\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-a010c0db-02ef-43d8-891f-7c7363e9dc93\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-f09c3c39-7cc4-4298-bc27-6de0dfdcfd6a\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/08\/2019_RTN_LaLettreInfo_Aout.pdf\">2019_RTN_LaLettreInfo_Aout<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/08\/2019_RTN_LaLettreInfo_Aout.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f09c3c39-7cc4-4298-bc27-6de0dfdcfd6a\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-0ba247ae-46e6-407f-989c-bafd7a15429e\" href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/08\/WS_5juillet_2019.pptx\">2019_RTN Compte-rendu Workshop \u00ab\u00a0Target Definition\u00a0\u00bb<\/a><a href=\"http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/08\/WS_5juillet_2019.pptx\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-0ba247ae-46e6-407f-989c-bafd7a15429e\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<div class='wp-block-file'><a href='http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/04\/2019_RTN_LaLettreInfo_Avril.pdf'>2019_RTN_LaLettreInfo_Avril<\/a><a href='http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/04\/2019_RTN_LaLettreInfo_Avril.pdf' class='wp-block-file__button' download>T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<div class='wp-block-file'><a href='http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/03\/2019_RTN_LaLettreInfo_Janvier.pdf'>2019_RTN_LaLettreInfo_Janvier<\/a><a href='http:\/\/radiotransnet.fr\/wp-content\/uploads\/2019\/03\/2019_RTN_LaLettreInfo_Janvier.pdf' class='wp-block-file__button' download>T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<p><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vous trouverez ici les donn\u00e9es de l&rsquo;observatoire de la recherche pr\u00e9clinique 2022 Brief communication RadioTransNet, Radiotherapy Translational and Preclinical Research Network: Results from the dedicated French cancer institute (INCa) call for projects RadioTransNet, r\u00e9seau national de recherche pr\u00e9clinique en radioth\u00e9rapie : r\u00e9sultats de l\u2019appel \u00e0 projets de l\u2019Institut National du Cancer \u00c9 Bayart, R De [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":41,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/with_image.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/pages\/85"}],"collection":[{"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/comments?post=85"}],"version-history":[{"count":33,"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/pages\/85\/revisions"}],"predecessor-version":[{"id":2683,"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/pages\/85\/revisions\/2683"}],"up":[{"embeddable":true,"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/pages\/41"}],"wp:attachment":[{"href":"https:\/\/radiotransnet.fr\/index.php\/wp-json\/wp\/v2\/media?parent=85"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}